BI
ONC

Binnacle Investments’s BeOne Medicines Ltd ONC Stock Holding History

Binnacle Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.77K Buy
14
+8
+133% +$2.43K ﹤0.01% 539
2025
Q2 		$1.45K Buy
+6
New +$1.47K ﹤0.01% 618

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Binnacle Investments's ONC Position: Q3 2025 in Review

Binnacle Investments increased its BeOne Medicines Ltd (ONC) stake by 133% in Q3 2025, buying an estimated $2.43K and bringing the position to 14 shares worth $4.77K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Binnacle Investments first reported a position in ONC in Q2 2025 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Binnacle Investments held 14 shares of BeOne Medicines Ltd worth $4.77K as of Q3 2025.
  • Binnacle Investments bought 8 BeOne Medicines Ltd shares in Q3 2025, an estimated $2.43K.
  • BeOne Medicines Ltd made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #539 holding.
  • Binnacle Investments first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.